Robot-assisted Endoscope Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By End User (Hospitals, Outpatient Facilities, Others), By Region & Competition, 2021-2031F
The Global Robot-assisted Endoscope Market is projected to expand from USD 1.51 Billion in 2025 to USD 2.36 Billion by 2031, reflecting a CAGR of 7.73%. These electromechanical devices are engineered to augment physician capabilities during gastrointestinal diagnostic and therapeutic procedures, offering superior stability, visualization, and dexterity compared to traditional manual instruments. Market growth is largely driven by the rising prevalence of chronic digestive disorders and a growing preference for minimally invasive interventions that shorten hospitalization times. Highlighting the significant disease burden necessitating such technologies, the American Cancer Society reported that approximately 152,810 new cases of colorectal cancer were estimated to be diagnosed in the United States in 2024.
Despite these strong growth drivers, the market encounters substantial obstacles due to the high capital acquisition and maintenance costs linked to robotic platforms. This financial barrier restricts adoption, particularly among smaller healthcare facilities and in developing regions where reimbursement frameworks may be inadequate. Additionally, the steep learning curve required for medical professionals to master these complex systems creates an operational bottleneck. These economic and training constraints continue to hinder the widespread integration of robot-assisted technologies into standard clinical practice.
Market Driver
Advancements in artificial intelligence and the creation of flexible robotic platforms are fundamentally transforming the Global Robot-assisted Endoscope Market by enabling access to anatomical structures that were previously unreachable. Innovations in soft robotics and steerable catheters allow physicians to navigate complex pathways within the lungs and gastrointestinal tract with greater stability and precision than manual instruments. This technical progress is validating the safety of complex platforms and accelerating their commercialization path. A significant milestone occurred in December 2024, when EndoQuest Robotics announced via press release that the U.S. FDA granted an Investigational Device Exemption (IDE) for its flexible Endoluminal Surgical System to commence trials for colorectal procedures, confirming the maturity of these technologies for clinical adoption.
The growing prevalence of pulmonary and gastrointestinal disorders significantly fuels market expansion as healthcare providers face increasing pressure to perform biopsies and therapeutic interventions with minimal trauma. The rising incidence of complex conditions, such as lung cancer, necessitates advanced diagnostic tools capable of delivering higher yield rates for early-stage detection, thereby driving the utilization of robot-assisted bronchoscopy. For instance, the American Lung Association?s '2024 State of Lung Cancer' report projected approximately 235,000 new lung cancer diagnoses in the United States in 2024. This escalating disease volume directly boosts procedure counts for established platforms; consequently, Intuitive Surgical reported in its October 2024 financial results that procedure volume for the Ion endoluminal system grew by approximately 73% year-over-year, underscoring the rapid clinical integration of these technologies.
Market Challenge
The primary obstacle hindering the growth of the Global Robot-assisted Endoscope Market is the high capital acquisition and maintenance costs associated with these advanced platforms. This substantial financial burden limits market penetration, particularly within smaller community hospitals and ambulatory surgical centers operating on narrow margins. When healthcare facilities face budget constraints, they often prioritize essential operational expenses over investing in premium, high-cost technologies that lack robust reimbursement pathways. Consequently, the difficulty in justifying the return on investment for these expensive systems directly stalls the broader adoption of robot-assisted endoscopy.
This economic pressure is further evidenced by recent industry data highlighting the financial strain on healthcare providers. According to the American Hospital Association, the average age of hospital plant and capital equipment increased by over 10% in 2024 as facilities were forced to delay purchasing new medical technologies due to rising operational costs and insufficient reimbursement. This contraction in capital spending power negatively impacts the robot-assisted endoscope market, as healthcare administrators are compelled to defer or cancel the acquisition of high-value electromechanical devices in favor of maintaining existing, lower-cost manual instruments.
Market Trends
The development of telesurgery and remote clinical monitoring solutions is expanding the availability of specialized gastrointestinal care by overcoming geographical limitations. Advanced robotic systems integrated with low-latency communication networks now allow expert physicians to manipulate endoscopes from distant locations, ensuring that patients in underserved regions can receive timely interventions without the need for travel. This capability is particularly vital for complex procedures where the requisite technical expertise is concentrated in major medical centers, effectively democratizing access to high-quality diagnostics. Validating this remote potential, Healthcare IT News reported in September 2024 that researchers from the Chinese University of Hong Kong and ETH Zurich successfully conducted a biopsy on a live porcine model over a distance of 5,700 miles, controlling a magnetic endoscope in Hong Kong from a console in Switzerland.
Simultaneously, the emergence of autonomous navigation and magnetic steering capabilities is revolutionizing the invasiveness and workflow of endoscopic examinations. Unlike traditional manually pushed instruments or mechanically actuated catheters, these next-generation platforms utilize external magnetic fields to precisely guide ingestible capsules or soft scopes through the digestive tract, significantly reducing patient discomfort and often eliminating the need for sedation. This shift toward magnetically driven, tether-free mobility minimizes tissue trauma and streamlines the procedural footprint, facilitating use in diverse clinical settings. Highlighting the commercial momentum of this technology, The Robot Report noted in June 2024 that Endiatx secured $7 million in funding to advance the clinical development of its PillBot system, a swallowable robotic capsule that physicians can actively steer inside the stomach.
Key Market Players
In this report, the Global Robot-assisted Endoscope Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Robot-assisted Endoscope Market.
Available Customizations:
Global Robot-assisted Endoscope Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Despite these strong growth drivers, the market encounters substantial obstacles due to the high capital acquisition and maintenance costs linked to robotic platforms. This financial barrier restricts adoption, particularly among smaller healthcare facilities and in developing regions where reimbursement frameworks may be inadequate. Additionally, the steep learning curve required for medical professionals to master these complex systems creates an operational bottleneck. These economic and training constraints continue to hinder the widespread integration of robot-assisted technologies into standard clinical practice.
Market Driver
Advancements in artificial intelligence and the creation of flexible robotic platforms are fundamentally transforming the Global Robot-assisted Endoscope Market by enabling access to anatomical structures that were previously unreachable. Innovations in soft robotics and steerable catheters allow physicians to navigate complex pathways within the lungs and gastrointestinal tract with greater stability and precision than manual instruments. This technical progress is validating the safety of complex platforms and accelerating their commercialization path. A significant milestone occurred in December 2024, when EndoQuest Robotics announced via press release that the U.S. FDA granted an Investigational Device Exemption (IDE) for its flexible Endoluminal Surgical System to commence trials for colorectal procedures, confirming the maturity of these technologies for clinical adoption.
The growing prevalence of pulmonary and gastrointestinal disorders significantly fuels market expansion as healthcare providers face increasing pressure to perform biopsies and therapeutic interventions with minimal trauma. The rising incidence of complex conditions, such as lung cancer, necessitates advanced diagnostic tools capable of delivering higher yield rates for early-stage detection, thereby driving the utilization of robot-assisted bronchoscopy. For instance, the American Lung Association?s '2024 State of Lung Cancer' report projected approximately 235,000 new lung cancer diagnoses in the United States in 2024. This escalating disease volume directly boosts procedure counts for established platforms; consequently, Intuitive Surgical reported in its October 2024 financial results that procedure volume for the Ion endoluminal system grew by approximately 73% year-over-year, underscoring the rapid clinical integration of these technologies.
Market Challenge
The primary obstacle hindering the growth of the Global Robot-assisted Endoscope Market is the high capital acquisition and maintenance costs associated with these advanced platforms. This substantial financial burden limits market penetration, particularly within smaller community hospitals and ambulatory surgical centers operating on narrow margins. When healthcare facilities face budget constraints, they often prioritize essential operational expenses over investing in premium, high-cost technologies that lack robust reimbursement pathways. Consequently, the difficulty in justifying the return on investment for these expensive systems directly stalls the broader adoption of robot-assisted endoscopy.
This economic pressure is further evidenced by recent industry data highlighting the financial strain on healthcare providers. According to the American Hospital Association, the average age of hospital plant and capital equipment increased by over 10% in 2024 as facilities were forced to delay purchasing new medical technologies due to rising operational costs and insufficient reimbursement. This contraction in capital spending power negatively impacts the robot-assisted endoscope market, as healthcare administrators are compelled to defer or cancel the acquisition of high-value electromechanical devices in favor of maintaining existing, lower-cost manual instruments.
Market Trends
The development of telesurgery and remote clinical monitoring solutions is expanding the availability of specialized gastrointestinal care by overcoming geographical limitations. Advanced robotic systems integrated with low-latency communication networks now allow expert physicians to manipulate endoscopes from distant locations, ensuring that patients in underserved regions can receive timely interventions without the need for travel. This capability is particularly vital for complex procedures where the requisite technical expertise is concentrated in major medical centers, effectively democratizing access to high-quality diagnostics. Validating this remote potential, Healthcare IT News reported in September 2024 that researchers from the Chinese University of Hong Kong and ETH Zurich successfully conducted a biopsy on a live porcine model over a distance of 5,700 miles, controlling a magnetic endoscope in Hong Kong from a console in Switzerland.
Simultaneously, the emergence of autonomous navigation and magnetic steering capabilities is revolutionizing the invasiveness and workflow of endoscopic examinations. Unlike traditional manually pushed instruments or mechanically actuated catheters, these next-generation platforms utilize external magnetic fields to precisely guide ingestible capsules or soft scopes through the digestive tract, significantly reducing patient discomfort and often eliminating the need for sedation. This shift toward magnetically driven, tether-free mobility minimizes tissue trauma and streamlines the procedural footprint, facilitating use in diverse clinical settings. Highlighting the commercial momentum of this technology, The Robot Report noted in June 2024 that Endiatx secured $7 million in funding to advance the clinical development of its PillBot system, a swallowable robotic capsule that physicians can actively steer inside the stomach.
Key Market Players
- Asensus Surgical Inc
- Intuitive Surgical Inc
- Auris Health Inc
- Johnson & Johnson Services, Inc.
- Brainlab AG
- Medtronic PLC
- Boston Scientific Corp
- Stryker Corp
In this report, the Global Robot-assisted Endoscope Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Robot-assisted Endoscope Market, By End User
- Hospitals
- Outpatient Facilities
- Others
- Robot-assisted Endoscope Market, By Region
- North America
- United States
- Canada
- Mexico
- Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- South America
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
Company Profiles: Detailed analysis of the major companies present in the Global Robot-assisted Endoscope Market.
Available Customizations:
Global Robot-assisted Endoscope Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL ROBOT-ASSISTED ENDOSCOPE MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By End User (Hospitals, Outpatient Facilities, Others)
5.2.2. By Region
5.2.3. By Company (2025)
5.3. Market Map
6. NORTH AMERICA ROBOT-ASSISTED ENDOSCOPE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By End User
6.2.2. By Country
6.3. North America: Country Analysis
6.3.1. United States Robot-assisted Endoscope Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By End User
6.3.2. Canada Robot-assisted Endoscope Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By End User
6.3.3. Mexico Robot-assisted Endoscope Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By End User
7. EUROPE ROBOT-ASSISTED ENDOSCOPE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By End User
7.2.2. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Robot-assisted Endoscope Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By End User
7.3.2. France Robot-assisted Endoscope Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By End User
7.3.3. United Kingdom Robot-assisted Endoscope Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By End User
7.3.4. Italy Robot-assisted Endoscope Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By End User
7.3.5. Spain Robot-assisted Endoscope Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By End User
8. ASIA PACIFIC ROBOT-ASSISTED ENDOSCOPE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By End User
8.2.2. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Robot-assisted Endoscope Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By End User
8.3.2. India Robot-assisted Endoscope Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By End User
8.3.3. Japan Robot-assisted Endoscope Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By End User
8.3.4. South Korea Robot-assisted Endoscope Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By End User
8.3.5. Australia Robot-assisted Endoscope Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By End User
9. MIDDLE EAST & AFRICA ROBOT-ASSISTED ENDOSCOPE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By End User
9.2.2. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Robot-assisted Endoscope Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By End User
9.3.2. UAE Robot-assisted Endoscope Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By End User
9.3.3. South Africa Robot-assisted Endoscope Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By End User
10. SOUTH AMERICA ROBOT-ASSISTED ENDOSCOPE MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By End User
10.2.2. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Robot-assisted Endoscope Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By End User
10.3.2. Colombia Robot-assisted Endoscope Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By End User
10.3.3. Argentina Robot-assisted Endoscope Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL ROBOT-ASSISTED ENDOSCOPE MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Asensus Surgical Inc
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Intuitive Surgical Inc
15.3. Auris Health Inc
15.4. Johnson & Johnson Services, Inc.
15.5. Brainlab AG
15.6. Medtronic PLC
15.7. Boston Scientific Corp
15.8. Stryker Corp
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. GLOBAL ROBOT-ASSISTED ENDOSCOPE MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By End User (Hospitals, Outpatient Facilities, Others)
5.2.2. By Region
5.2.3. By Company (2025)
5.3. Market Map
6. NORTH AMERICA ROBOT-ASSISTED ENDOSCOPE MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By End User
6.2.2. By Country
6.3. North America: Country Analysis
6.3.1. United States Robot-assisted Endoscope Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By End User
6.3.2. Canada Robot-assisted Endoscope Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By End User
6.3.3. Mexico Robot-assisted Endoscope Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By End User
7. EUROPE ROBOT-ASSISTED ENDOSCOPE MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By End User
7.2.2. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Robot-assisted Endoscope Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By End User
7.3.2. France Robot-assisted Endoscope Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By End User
7.3.3. United Kingdom Robot-assisted Endoscope Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By End User
7.3.4. Italy Robot-assisted Endoscope Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By End User
7.3.5. Spain Robot-assisted Endoscope Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By End User
8. ASIA PACIFIC ROBOT-ASSISTED ENDOSCOPE MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By End User
8.2.2. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Robot-assisted Endoscope Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By End User
8.3.2. India Robot-assisted Endoscope Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By End User
8.3.3. Japan Robot-assisted Endoscope Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By End User
8.3.4. South Korea Robot-assisted Endoscope Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By End User
8.3.5. Australia Robot-assisted Endoscope Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By End User
9. MIDDLE EAST & AFRICA ROBOT-ASSISTED ENDOSCOPE MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By End User
9.2.2. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Robot-assisted Endoscope Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By End User
9.3.2. UAE Robot-assisted Endoscope Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By End User
9.3.3. South Africa Robot-assisted Endoscope Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By End User
10. SOUTH AMERICA ROBOT-ASSISTED ENDOSCOPE MARKET OUTLOOK
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By End User
10.2.2. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Robot-assisted Endoscope Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By End User
10.3.2. Colombia Robot-assisted Endoscope Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By End User
10.3.3. Argentina Robot-assisted Endoscope Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By End User
11. MARKET DYNAMICS
11.1. Drivers
11.2. Challenges
12. MARKET TRENDS & DEVELOPMENTS
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. GLOBAL ROBOT-ASSISTED ENDOSCOPE MARKET: SWOT ANALYSIS
14. PORTER'S FIVE FORCES ANALYSIS
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. COMPETITIVE LANDSCAPE
15.1. Asensus Surgical Inc
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Intuitive Surgical Inc
15.3. Auris Health Inc
15.4. Johnson & Johnson Services, Inc.
15.5. Brainlab AG
15.6. Medtronic PLC
15.7. Boston Scientific Corp
15.8. Stryker Corp
16. STRATEGIC RECOMMENDATIONS
17. ABOUT US & DISCLAIMER
